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The article is focused on the role of the cell bioenergetic apparatus, mitochondria,
involved in development of immediate and delayedmolecular mechanisms for adaptation
to hypoxic stress in brain cortex. Hypoxia induces reprogramming of respiratory chain
function and switching from oxidation of NAD-related substrates (complex I) to succinate
oxidation (complex II). Transient, reversible, compensatory activation of respiratory chain
complex II is a major mechanism of immediate adaptation to hypoxia necessary for (1)
succinate-related energy synthesis in the conditions of oxygen deficiency and formation
of urgent resistance in the body; (2) succinate-related stabilization of HIF-1α and
initiation of its transcriptional activity related with formation of long-term adaptation; (3)
succinate-related activation of the succinate-specific receptor, GPR91.This mechanism
participates in at least four critical regulatory functions: (1) sensor function related with
changes in kinetic properties of complex I and complex II in response to a gradual
decrease in ambient oxygen concentration; this function is designed for selection of
the most efficient pathway for energy substrate oxidation in hypoxia; (2) compensatory
function focused on formation of immediate adaptive responses to hypoxia and hypoxic
resistance of the body; (3) transcriptional function focused on activated synthesis of
HIF-1 and the genes providing long-term adaptation to low pO2; (4) receptor function,
which reflects participation of mitochondria in the intercellular signaling system via the
succinate-dependent receptor, GPR91. In all cases, the desired result is achieved by
activation of the succinate-dependent oxidation pathway, which allows considering
succinate as a signaling molecule. Patterns of mitochondria-controlled activation of
GPR-91- and HIF-1-dependent reaction were considered, and a possibility of their
participation in cellular-intercellular-systemic interactions in hypoxia and adaptation was
proved.
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Mitochondrial Signaling Function and the Body Vital Activity
Oxygen dependence and capability for maintaining the oxygen homeostasis are the
properties of all higher organisms whose vital activity is related with aerobic energy
production due to functioning of the respiratory chain in the inner mitochondrial
membrane. Inhaled air reflects the state and oxygen demand of mitochondria (Balaban,
1977; Chandel and Schumacker, 2000; Duchen et al., 2003; Duchen, 2004; Gnaiger, 2005;
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Das, 2006; Devin and Rigoulet, 2007; Kann and Kovacs, 2007;
Wheaton and Chandel, 2011).
In mammals, up to 98% of body consumed oxygen is related
with oxidative phosphorylation, a process occurring in the
respiratory chain, where O2 is the final acceptor of electrons
delivered by NADH and flavoproteins (Silver and Erecinska,
1998).The electromotive force generated in this process is used
for formation of membrane potential and ATP synthesis, which
are required for various energy-dependent reactions responsible
for maintaining the cell vitality.
Mitochondria, being oxygen-dependent, are a target for
hypoxia/ischemia. Shortage of cell environmental oxygen
decreases aerobic synthesis and content of high-energy
compounds (ATP, CP) and reduces the membrane potential
required for maintaining energy demands and the osmotic
balance. These factors, in turn, lead to depression of multiple
energy-dependent reactions involved in ion transport,
electrogenic and receptor cell function, muscle contractions,
respiration, etc. The most typical disorders are membrane
depolarization, uncontrolled Ca2+ entry through voltage-
dependent Ca2+ channels, activation of Ca2+ -dependent
phospholipases and proteases, uncontrolled swelling of cells,
hydrolysis of most cell components, and, finally, necrosis.
Thereby, mitochondrial dysfunction induced by hypoxia may
initiate development of various abnormalities and even cause
fatality (Acker, 1994; Lukyanova, 1997, 2014; Rumsey et al.,
1999; Wenger, 2000; Peers and Kemp, 2001; Lutz and Prentis,
2002; Michiels, 2004; Gnaiger, 2005; Heerlein et al., 2005; Larsen
et al., 2006; Seppet et al., 2009; Wheaton and Chandel, 2011;
Lukyanova et al., 2013).
Brain is one of the most oxygen-dependent organs (Siesjo,
1978; Nicholls and Budd, 2000; Bickler and Donohoe, 2002;
Neubauer and Sunderram, 2004; Kann and Kovacs, 2007). Brain
uses up to 20% of consumed oxygen, although the brain weight
constitutes only 2% of body weight (Siesjo, 1978; Silver and
Erecinska, 1998). Brain is characterized by high expenditure
of energy and low energy reserve. Furthermore, maintenance
of energy-dependent process takes 80% of ATP produced in
neuronal mitochondria. For this reason, the brain is extremely
sensitive to hypoxia, particularly specific brain regions, such as
the cortex and hippocampus. All this makes essential the insight
into functioning of the brain mitochondrial apparatus in the
conditions of insufficient oxygen supply.
According to current concepts, mitochondria are an
evolutionary product of endosymbiosis, a process that has
occurred 2–4 billion years ago. This process involved fusion
of two akaryocytes, an anaerobic bacterial cell, the “host,” and
a proteobacterium symbiont, which possessed a respiratory
apparatus including elements of the tricarbonic acid cycle
Abbreviations: ATP, adenosine triphosphate; ADP, adenosine diphosphate; BC,
brain cortex; C-I, II, III, IV, mitochondrial complexes I, II, III, IV; GABA,
gamma-aminobutyric acid; GPR91, succinate-related guanine nucleotide - binding
protein-coupled receptor; HBH, hypobaric hypoxia; HIF, hypoxia-inducible factor;
HRE, hypoxia response element; HR, high-resistance rats; LR, low-resistance
rats; NAD, NADH, nicotine adenine nucleotides; PC, phosphocreatine; PDH –
HIF prolyl-hydroxylase; PDK, pyruvate dehydrogenase kinase; SDH, succinate
dehydrogenase.
(TAC), a respiratory chain, and oxidative phosphorylation
(Margulis, 1981; Alberts et al., 1989; Gray et al., 1999, 2001;
Martin et al., 2001; Henze andMartin, 2003; Duchen, 2004; Gray,
2012). In this symbiosis, the future symbiont mitochondrion
(promitochondrion) provided the host cell with energy, which
was produced by a very economical, aerobic way, while the
host cell, in turn, synthesized metabolites necessary for the
mitochondrion. During the development of endosymbiotic
interrelations, proteobacteria transferred many genes to the
host cell nucleus, which had formed due to the increased
energy efficiency. This process resulted in simplification of
the promitochondrion endosymbiont, which evolved from an
independent microorganism into a cell organelle. In this way,
the symbiont cells turned into mitochondria whereas host cells
turned into eukaryocytes. Due to the endosymbiotic relations,
the pro-eukaryocyte has received not only energetic advantages
but also a chance for survival in the conditions of gradual oxygen
accumulation in the atmosphere, which had initially contained
very little oxygen, less than 0.1%. Before oxygen enrichment of
the atmosphere, all forms of life that existed in the biosphere of
that time, were anaerobic (Margulis, 1981; Alberts et al., 1989;
Gray et al., 1999, 2001; Martin et al., 2001; Henze and Martin,
2003; Duchen, 2004; Gray, 2012).
Current mitochondria are unique cytoplasmic organelles
characteristic of eukaryotes, i.e., the organisms with cells
containing formed, membrane-confined nuclei. Due to their
origin, mitochondria possess three distinctive features of
structural organization, which differ it from all other intracellular
organelles: (1) presence of respiratory chain enzymes designed
for aerobic energy production and arranged into four complexes.
These complexes are capable for uniting into supercomplexes
(respirasomes), which stabilizes the electron transport chain
performance, increases the electron transport velocity, may
involve substrate channeling, and restricts generation of reactive
oxygen species as a by-product (Acín-Pérez et al., 2004;
Schagger et al., 2004; McKenzie et al., 2006; Schäfer et al.,
2006; Starkov, 2008); (2) presence of its own genome, which
allows renewing components of respiratory chain complexes,
the most functionally important proteins, independently on
the nucleus genome in the conditions of intensive functional
loads; and (3) capability for motion, including division, fusion,
and intracellular traveling (Kuznetsov et al., 1994, 2004; Gray
et al., 1999, 2001; Kaasik et al., 2001; Martin et al., 2001;
Henze and Martin, 2003; Chen and Chan, 2005; Kuznetsov
and Margreiter, 2009; Gray, 2012; Van der Bliek et al., 2013).
Due to the latter property known in scientific literature as
“mitochondrial dynamics,” mitochondria can form functional
complexes with the endoplasmic reticulum and cytoskeletal
structures (intracellular functional energetic units, mitochondrial
reticulum). These complexes provide energy metabolism in
local energy-transportation networks. In these complexes,
ADP diffusion is facilitated, and a system of channels for
metabolite exchange is available. The capability of mitochondria
for structural remodeling and metabolic reprogramming is a
basis mechanism inseparably linked with mitochondrial energy
production, which provides interaction of mitochondria with
each other and with other cell structures and systems. Therefore,
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in the process of evolution, the mitochondrial major function
of aerobic energy production has allowed mitochondria to
become involved in regulation of various physiological functions
by providing energy to most of intracellular processes necessary
for the body vital activity (Kaasik et al., 2001; Appaix et al., 2003;
Chen and Chan, 2005, 2009; Schäfer et al., 2006; Kuznetsov and
Margreiter, 2009; Van der Bliek et al., 2013).
Mitochondria actively participate in cell metabolism. They
contain many key, limiting enzymes for fatty acid oxidation,
steroid biosynthesis, heme synthesis, insulin secretion in β-cells
(MacDonald et al., 2005) and gastric juice secretion (Kennedy
and Lehninger, 1949; Gnaiger et al., 2000; Duchen et al., 2003;
Duchen, 2004; Gnaiger, 2005). Mitochondria participate in
regulation of cell redox potential (Meister, 1995) and protein
import (Wiedemann et al., 2004). In addition, mitochondria
contribute to intracellular signaling and regulation with a
central role in keeping homeostatic cell ionic composition
(Chandel, 1990; Chandel and Schumacker, 2000; Butow and
Avadhani, 2004; Darley-Usmar, 2004). A system of regulatory
interaction related with Ca2+ and K+- metabolism exists between
mitochondria and the endoplasmic reticulum (Gunter and
Gunter, 1994; Hansford and Zorov, 1998; Liu et al., 1998; Rizzuto
et al., 1998; Fiermonte, 1999; Da Silva et al., 2003).
A system exists that is connected to Ca2+ metabolism and
involves regulatory interactions between mitochondria and the
endoplasmic reticulum as well as between activation of G-
coupled surface receptors, the phosphatidyl-inositol-3-kinase
(PI3K) cascade, eNOS, guanylyl cyclase, and protein kinase G
(PKG), and performance of the mitochondrial ATP-sensitive
potassium (mitoKATP) channel (Wang and Semenza, 1993; Pek
and Lutz, 1998; Bernaudin et al., 2004; He et al., 2004; Murphy,
2004; Fan et al., 2010). Activated PKG opens the mitoKATP
channel, which results in increased ROS production followed
by activation of other kinases. In this system, PKG is the
terminal cytosolic component of the terminal signaling pathway
transmitting the cardioprotective signal from the cytosol to
the inner mitochondrial membrane through the protein kinase
C (PKC)-dependent pathway (Wang and Semenza, 1993; Zhu
and Bunn, 1999; Stroka et al., 2001; Semenza, 2002; Bruick,
2003; Butow and Avadhani, 2004; Murphy, 2004). In addition,
mitochondria participate in cell-to-cell interactions and systemic
regulation (Zhu and Bunn, 1999; Chandel and Schumacker, 2000;
Nicholls and Budd, 2000; Nishimura et al., 2001; Brunk and
Terman, 2002; Butow and Avadhani, 2004; Kuznetsov et al.,
2004; Michiels, 2004; Felty and Roy, 2005; MacDonald et al.,
2005; Lukyanova et al., 2008a, 2011). Mitochondria are the
major regulators of the oxygen homeostasis in the body. At
the systemic level, mitochondria determine the concentration
gradient for oxygen delivered from the environment to the
cell and represent the final step of interaction with molecular
oxygen (Brunk and Terman, 2002; Lukyanova et al., 2008a,
2011). Due to this function, which determines both viability
and vital activity of aerobic organisms, evolution has created
very sophisticated physiological systems for oxygen delivery to
mitochondria and maintenance of optimum oxygenation in cells
(act of breathing; pulmonary system of oxygen transportation;
cardiovascular circulatory system; blood mass-transfer system;
red cells; and hemoglobin) (Zhu and Bunn, 1999; Nicholls and
Budd, 2000; Prabhakar and Overholt, 2000; Di Lisa and Ziegler,
2001; Peers and Kemp, 2001; Brunk and Terman, 2002; Voos
and Rotgers, 2002; Da Silva et al., 2003; Duchen, 2004; Kuznetsov
et al., 2004; Michiels, 2004; Devin and Rigoulet, 2007).
Organization of the digestion system, including consumption
and subsequent stepwise enzymic processing of the food, is also
dictated primarily by the need for substrate supply to reactions
of mitochondrial oxidation and oxidative phosphorylation
(Michiels, 2004). The signaling function of mitochondria is
related with such processes as growth (Felty and Roy, 2005),
aging (McCarter, 1995; Brunk and Terman, 2002), response to
temperature (thermogenesis), apoptosis (Kroemer et al., 1998;
Nishimura et al., 2001), insulin secretion in β-cells (MacDonald
et al., 2005), and formation of adaptive responses (Bruick, 2003).
Mitochondria provide energy for physiological functions
involved in the body vital activity. These functions include,
first of all, maintenance of ion gradients in excitable tissues;
accumulation of vesicular secret; maintenance of hormonal
and neurotransmitter functions; contractility of the heart
and vascular, pulmonary and gastrointestinal smooth muscles;
fertilization and embryogenesis; and adaptation to stresses (Zhu
and Bunn, 1999; Nicholls and Budd, 2000; Di Lisa and Ziegler,
2001; Peers and Kemp, 2001; Voos and Rotgers, 2002; Da Silva
et al., 2003; Duchen, 2004; Kuznetsov et al., 2004; Devin and
Rigoulet, 2007; Seppet et al., 2009).
Therefore, the mitochondrial respiratory chain in involved
not only in the intracellular signaling, but also transmembrane
and intercellular signaling. Mitochondria themselves function
as active signaling organelles, which contribute to information
transmission in various intracellular signaling pathways, and play
a key role in most important regulatory physiological processes.
Regulatory Role of Mitochondria in
Hypoxia
The body response to hypoxia includes various adaptive
reactions, which facilitate elimination of functional and
metabolic disorders typical for hypoxia and focus primarily
on preservation of the mitochondrial function. In this process,
two types of mechanisms are used: (a) an urgent compensatory
mechanism designed for mobilization of immediate responses
to prevent or eliminate the disorders induced by acute hypoxia;
these responses provide fast recovery of the body in the
posthypoxic period; and (b) delayed mechanisms of adaptation
to hypoxia, which develop within a longer period and enhance
non-specific resistance to oxygen shortage. These mechanisms
are based on regulatory reprogramming of mitochondrial
complex function.
The mitochondrial respiratory chain consists of a series
of electron carriers that function as redox pairs and that
are mainly prosthetic groups of integral proteins. There are
four electron transfer or respiratory complexes (complexes I–
IV), each capable of catalyzing electron transfer in a partial
reaction of the respiratory chain. Complex I (NADH-ubiquinone
oxidoreductase) (C-I) is a multisubunit complex that possesses
the NADH-ubiquinone oxidoreductase activity. This largest
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component of the respiratory chain consists of at least 46
protein subunits (46–49) (Grivennikova et al., 2001). Seven
of which are encoded by the human mitochondrial genome.
Additionally, C-I contains stably bound cofactors, including
flavin mononucleotide and eight iron-sulfur clusters. C-II
(succinate-ubiquinone oxidoreductase) mediates the succinate
dehydrogenase (SDH) activity. C-III is ubiquinol-cytochrome c
reductase, while C-IV displays the cytochrome c oxidase activity.
The electrons resulting from the oxidative process are transferred
from C-I and C-II to C-III through ubiquinone and from C-III to
C-IV through cytochrome c as shuttles. Electron transfer through
complexes I, III, and IV is coupled to proton pumping, creating
the electrochemical gradient used by complex V (ATP synthase)
to synthesize ATP from ADP and in organic phosphate (Genova
et al., 1995; Brandt, 1997; Briére et al., 2004; Schagger et al., 2004;
Schäfer et al., 2006; Lenaz and Genova, 2007).
In the normoxic conditions, respiratory complexes are
assembled into supercomplexes. Complexes I, III, and IV exist
together as supramolecular assemblies called respirasomes.
The likely functions of the supercomplexes are facilitating
the electrons transfer between complexes and minimizing
the risk of releasing electrons. The assembly of a respirasome
might have advantages in substrate channeling of quinones
and/or cyt c, sequestration of reactive intermediates, and
stabilization of individual complexes. In humans, it was
shown that supercomplexes are essential for C-I stability
(Acín-Pérez et al., 2004; Schagger et al., 2004; Althoff
et al., 2011; Chen et al., 2012; Moreno-Lastres et al., 2012;
Winge, 2012). In contrast to the organized electron flow
by respiratory supercomplexes, mitochondrial C-II (SDH)
can function as an independent enzyme whose activity
is limited only by substrate availability (Hawkins et al.,
2010).
In normoxia, performance of the respiratory chain usually
depends on oxidation of NAD-dependent substrates, the major
supplier of reduction equivalents to the respiratory chain through
C-I (Figure 1A). Contribution of this pathway, as estimated by
oxygen consumption, predominates in intact cells. In brain, this
contribution may reach 90% relative to the total mitochondria
oxygen consumption (Lukyanova, 1997, 2014; Lukyanova et al.,
2009a, 2013). Nevertheless, in these conditions, a part of
mitochondrial respiration is related with the activity of an
alternative pathway of electron transport through C-II and
oxidation of succinate, a TAC cycle product found in relatively
low concentrations (0.2–0.4mM) in the normoxic mitochondrial
matrix (Hems and Brosnan, 1970; Komaromy-Hiller et al.,
1997). In normoxia, the ratio of the two oxidation pathways
(NAD-dependent and succinateoxidase) depends primarily on
properties of the major C-I and C-II enzymes, NADH-
ubiquinone oxidoreductase and SDH, respectively. Their kinetic
characteristics are tissue-specific and differ in animals with
different hypoxia tolerance (Lukyanova, 1988, 1997, 2005;
Dudchenko et al., 1993; Dudchenko and Luk’yanova, 1995, 1996;
Lukyanova and Dudchenko, 1999; Lukyanova et al., 2008b,
2009a,b).
Hypoxia induces regulatory reprogramming of the respiratory
chain, including reversible suppression of the C-1 electron
transport function and compensatory activation of C-
II Lukyanova, 1997; Lukyanova et al., 2008a, 2013). The
dissociation of C-I from the large supercomplexes occurs
under the hypoxic conditions, when succinate accumulates as a
substrate for C-II (Figure 1B) (Sanborn et al., 1979; Acín-Pérez
FIGURE 1 | Reprogramming of the respiratory chain function and switching from oxidation of NAD-related substrates (Complex I, C-I) in normoxia (A)
to succinate oxidation (C-II) in hypoxia (B). (A) Normoxia; high activity of C-I (70–80% of mitochondrial respiration), low activity of C-II (25–10% of mitochondrial
respiration); (B) hypoxia; depression of C-I, activation of C- II (90–75% of mitochondrial respiration).
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et al., 2004; Althoff et al., 2011; Chen et al., 2012; Moreno-Lastres
et al., 2012; Winge, 2012).
Hypoxia is associated with activation of succinate
dehydrogenase and succinate oxidation and with increased
contribution of the latter to respiration and energy production
(Acín-Pérez et al., 2004; Lenaz and Genova, 2007; Althoff et al.,
2011; Chen et al., 2012; Moreno-Lastres et al., 2012). The
contribution of succinate oxidase oxidation may reach 70–80%
(Lukyanova et al., 2008a, 2009a). Under these conditions,
mitochondrial C-II can function as an independent enzyme
whose activity is limited only by the substrate availability. The
C-II-driven electron flow is the primary way of mitochondrial
membrane polarization under the hypoxic conditions and
that lack of the C- II substrate succinate resulted in reversible
membrane potential loss that could be restored rapidly by
succinate supplementation (Nowak et al., 2008; Hawkins et al.,
2010). The inhibition of mitochondrial C-II also leads to
mitochondrial depolarization and mimics hypoxia in cells. The
effect of reversible inactivation of the C-I electron transport
function in hypoxia is the first stage in the development of
hypoxia-induced mitochondrial disorders, which correlate
with functional and metabolic phase changes observed at the
systemic level (Lukyanova, 1997; Lukyanova et al., 2009b, 2013;
Lukyanova, 2014).
At present time, much experimental evidence is available
in support of hypoxia-induced disorders in the C-I electron
transport function. These disorders persist and even increase in
the early posthypoxic period (first 30min to 2 h of reoxygenation)
and are known as mitochondrial dysfunction (Rouslin and
Millard, 1980; Lukyanova, 1988; Genova et al., 1995; Pitkanen
and Robinson, 1996; Robinson, 1998; Chávez et al., 2000; Kunz
et al., 2000; Weinberg et al., 2000; Maklashinas et al., 2002; Da
Silva et al., 2003; Feldkamp et al., 2004; Sadek et al., 2004; Regard
et al., 2008; Lukyanova et al., 2009a).
Also, much evidence exists for a special role of succinate
in tissue oxygen metabolism at early hypoxia. Thus, tissue
and blood content of succinate was shown to increase by an
order of magnitude up to 4–7mM already in the first 30min of
hypoxia, and to continue growing through early reoxygenation,
which allowed some researchers to consider succinate a hypoxia
marker molecule (Hems and Brosnan, 1970; Hochachka and
Dressendorfer, 1976; Taegmeyer, 1978; Hohl et al., 1987;
Komaromy-Hiller et al., 1997; Hochachka and Somero, 2001;
Kushnir et al., 2001).
The activation of succinate oxidase oxidation in these
conditions should be regarded as an evolutionarily formed,
urgent, protective, regulatory, and compensatory mechanism,
which occurs in most tissues under any form of oxygen shortage
and provides preservation of the aerobic energy production
during early disorders of the oxygen homeostasis (Lukyanova,
1997; Lukyanova et al., 2009a, 2013). If this switch does not
happen, the uncompensated hypoxic dysfunction of C-I results
in acute de-energization (decreased membrane potential; loss of
ATP and changes in the adenine nucleotide pool; and respiration
disorders due to oxidation of NAD-dependent substrates, the
electron donators for C-I) (Dudchenko et al., 1993; Dudchenko
and Luk’yanova, 1996; Lukyanova, 1997, 2005; Lukyanova and
Dudchenko, 1999; Lukyanova, 2005; Lukyanova et al., 2009a).
All this taken together precedes changes in other functional
and metabolic parameters that control the cell vital activity,
including condensation of the mitochondrial matrix; disturbed
calcium and potassium homeostasis; disordered expression of
themitochondrial genome; generation of reactive oxygen species;
loss of CoQ; exit of cytochrome c to the intermembrane space;
apoptosis; and impaired capability of cells for adaptation to
low pO2. These processes are associated with an increased
lactate/pyruvate ratio; changes in the cell redox potential;
metabolic acidosis; and impairment of various energy-dependent
processes (such as the electrogenic function of electro-excitable
cells and anabolic processes, including urea synthesis, phase II
biotransformation reactions, etc.
Features of Respiratory Chain
Reprogramming in Hypoxic Brain Cortex
The described above hypoxia-induced changes in the
performance of respiratory chain are universal and occur
in all tissues, although they are tissue-specific. This process is
particularly important for the brain, since the major energetic
substrate of oxidation in brain is glucose, which is metabolized to
pyruvate in the process of glycolysis. In the aerobic conditions,
pyruvate is oxidized in TCA cycle reactions in the NAD-
dependent pathway. In the normoxic brain cortex (BC), this
oxidation pathway may use up to 90% of consumed oxygen
(Lukyanova, 1997). However it should be taken into account that
pheno- and genotypic features of the body response to hypoxia
are critically important1. Furthermore, individual differences
in the response to hypoxia manifest themselves not only at the
systemic level but also at the cellular and subcellular levels.
Thus, processes of oxidative phosphorylation were
shown to be fundamentally different in BC mitochondria
of intact hypoxia high-resistant (HR) and low-resistant
(LR) rats. In BC of normoxic LR, the baseline similarity of
oxidative phosphorylation efficiency is due to a higher rate of
phosphorylating respiration, which indicates less economy of
this process at baseline. In addition, during oxidation of NAD-
dependent substrates by LR BC mitochondria, the velocity of
electron transport in the respiratory chain is maximum and may
exhaust its reserve capacity, should the functional load increase;
this is not observed in the brain of HR animals (Luk’yanova et al.,
1991; Dudchenko et al., 1993; Lukyanova et al., 2009a,c).
1Any population of animals is known to contain animals with dissimilar tolerance
to hypoxia, which correlates with features of the higher nervous system and the
functional metabolic profile (Lukyanova, 1997; Lukyanova et al., 2008b, 2009a,b).
This dissimilarity is based on differences in the state of the central nervous
system, neuro-humoral regulation, stress-activating, and stress-limiting systems,
oxygen transporting function of blood, and the state of membranes and receptors.
Low-resistant (LR) animals are considered to have a weak type of the nervous
system, increased excitability and emotional reactivity, less developed internal
inhibition, and high exhaustibility of excitation. LR animals respond to hypoxia
with agitation and high locomotor activity. In LR rats, acute hypoxia results in a
greater variety of functional and metabolic parameters than in high-resistant (HR)
rats. In contrast, HR to hypoxia animals have reduced excitability and anxiety,
milder aggressiveness, more pronounced internal inhibition, low sensitivity to any
provocative factors, and tendency to social domination. Acute hypoxia induces
an inhibitory response in HR rats (Goryacheva et al., 1993; Livanova et al., 1992;
Lukyanova, 1997, 2005; Lukyanova et al., 2009c).
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Differences in the oxidative capacity of the NAD-dependent
substrate region in the BC respiratory chain of HR and LR
animals reflect peculiarities of kinetic characteristics for some
of respiratory chain enzymes. Thus, in the normoxic BC of
LR rats, maximum activity and KM values (NADH) of NADH-
cytochrome c reductase, the main C-I enzyme, are significantly
lower than in the BC of HR rats (Dudchenko et al., 1993;
Dudchenko and Luk’yanova, 1995, 1996; Lukyanova, 1997, 2005,
2014; Lukyanova et al., 2013). Similar, though less pronounced
differences in values of kinetic parameters are typical for
cytochrome oxidase in BC of HR and LR animals. Therefore,
in the LR BC, these enzymes faster become saturated with the
enzyme-specific substrates (NADH or cyt-c) and slower oxidize
them, whichmay result in lower activity and faster inactivation of
C-I (Dudchenko and Luk’yanova, 1995, 1996; Luk’yanova et al.,
1995).
The differences in kinetic parameters of respiratory chain
enzymes remain also in oxygen-deficient BC of HR and LR
animals. For example, in the neocortex of LR rats, any hypoxia
exposure induced opposite changes in KM values of both complex
enzymes—increased NADH-ubiquinone oxidoreductase (C-I)
KM and decreased SDH KM (C-II). This process reflects reduced
and increased efficiency of the enzyme in the first and the second
instances, respectively. For this reason, the suppression of BC
C-I activity occurs earlier and is more marked in LR rats than
in HR rats. Therefore, in different forms of hypoxic exposure, the
switching of oxidation pathways for respiratory chain substrates
from the NAD-dependent pathway to the succinate pathway is
due to kinetic reasons (Luk’yanova et al., 1995). The existence
of different kinetic properties of respiratory chain enzymes
in HR and LR rat BC, a target for hypoxia, suggests that
this phenomenon is genetically predetermined, and the energy
metabolism is involved as a major factor determining formation
of individual resistance.
These features of C-I and C-II responses to hypoxia correlate
with changes in ATP content. Thus, evaluating the dependence
of intracellular ATP level on pO2 showed that a decrease in
ATP concentration in the LR rat BC began at higher pO2 values
and was much more pronounced than in HR rats (Dudchenko
et al., 1993; Dudchenko and Luk’yanova, 1995; Lukyanova and
Dudchenko, 1999). The hypoxic reprogramming of respiratory
chain substrate region not only prevents or alleviates disorders
of ATP synthesis and normalizes parameters of the adenylate
pool but also beneficially influences vital functions, stabilizes and
normalizes pH, eliminates acidosis typical for hypoxia (Maevsky
et al., 2001), and enhances resistance to the oxygen shortage
(Figure 1) (Taegmeyer, 1978; Weinberg et al., 2000; Lukyanova,
2005; Lukyanova et al., 2013; Lukyanova, 2014). This process
occurs rather rapidly. Changes in kinetic parameters of C-I and
C-II major enzymes were observed already at 30min of various
hypoxic exposures (Lukyanova et al., 2008b).
Analyzing effects of different hypoxic regimens on the
respiratory chain substrate region showed that regulatory
rearrangements of the respiratory chain performance
were qualitatively similar in all studied instances. These
rearrangements are aimed at activation of the succinate oxidase
pathway (C-II), which is energetically more efficient in the
hypoxic conditions (Hawkins et al., 2010). When changes in the
kinetic parameters of succinate oxidase oxidation were minor or
absent, the development of resistance was difficult (Lukyanova
et al., 2009a).
Qualitatively different changes in kinetic properties of
BC mitochondrial enzymes occur in long-term hypoxic
exposures, which provide formation of delayed adaptation
(lengthy stay in mountains, hypoxia courses in different
regimens). An undoubted sign of adaptation to high altitude
hypoxia is increased mitochondrial mass in tissues. The
increase in mitochondrial mass during long-term adaptation
to hypoxia correlated with activated synthesis of nucleic acids
and mitochondrial proteins to provide potentiation of the
mitochondrial apparatus. The increase in brain total protein
was associated with simultaneous increases in cytochromes,
including cytochrome aa3, which changed in the same way in
BC of both HR and LR animals. The cytochrome aa content
per unit tissue was increased and correlated with the increase in
mitochondrial mass and was decreased per unit mitochondrial
protein (Dudchenko and Luk’yanova, 1996; Lukyanova and
Dudchenko, 1999), which indicated a decreased amount of
respiratory transporters in the respiratory chain cytochrome
region. Furthermore, the decrease in oxidation rate of NAD-
dependent substrates was greater in the LR rat brain than in
HR rats.
However, the phosphorylation efficiency estimated by the
ATP/O ratio was higher after than before long-term adaptation to
hypoxia (Luk’yanova et al., 1990, 1991; Lukyanova et al., 2009b).
The increased efficiency of NAD-dependent substrate oxidation
together with the reduced electron transport function and the
increased amount of mitochondria suggest economization of
the energy production process in the brain of adapted rats.
Furthermore, the velocity of electron transport in the respiratory
chain was no longer limit as it had been before the adaptation,
and a “respiratory activity reserve” appeared. In contrast,
the “physiological range of respiratory activity” decreased. All
these processes were more pronounced in the BC of LR rats.
Taken together, these data suggest that long-term adaptation to
hypoxia restored the leading role of NAD-dependent oxidation
in the energy metabolism. Therefore, preserving high activity
of specifically these pathways is essential for development
of individual brain resistance to oxygen shortage. On the
contrary, the participation of succinate oxidase pathway in
energy metabolism during long-term adaptation to hypoxia
gradually declined, particularly in the brain of LR animals,
and the use of this pathway as a compensatory mechanism
became restricted (Lukyanova andDudchenko, 1999; Lukyanova,
2005).
Kinetic properties of mitochondrial enzymes also changed
in the process of long-term adaptation to hypoxia. In the
BC of LR rats adapted to hypoxia, Vmax values for NADH
cytochrome c reductase and cytochrome oxidase 1.5–2.5 times
increased while KM (cyt c) values decreased, and the Vmax
values approached or exceeded those for HR rat BC. In other
words, in the LR BC, activities of these enzymes increased during
adaptation to hypoxia whereas their substrate (NADH and cyt
c) affinity decreased (Lukyanova et al., 2008a). In the BC of HR
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rats, parameters of these enzymes remained unchanged or even
decreased.
The physiological significance of such transformation may be
that new isoforms of mitochondrial enzymes with new features
emerge in the LR BC during adaptation. These features allow
the enzymes to function in a broader range of their substrate
(NADH or reduced cyt c) concentrations and at higher rates.
The reduction degree of pyridine nucleotides and cytochromes,
specifically cyt c, increases in hypoxia. Therefore, emergence of
new kinetic properties in NADH cytochrome c reductase and
cytochrome oxidase may provide more effective performance of
these enzymes in long-term oxygen shortage. This may result in
higher resistance of LR BC mitochondria to acute hypoxia.
Therefore, the economization of energy production
characteristic of long-term adaptation to hypoxia is due to
emergence of a new mitochondrial population with new
properties, including the decreased content of respiratory
transporters in the respiratory chain terminal region and the
lower oxidizing capacity of these transporters, which, however,
work more efficiently due to the increase deficiency of oxidative
phosphorylation and the increased amount of mitochondria
in the cell. On the whole, both these processes focus on
replenishment of ATP losses, which should have occurred in
these conditions.
However, in long-term adaptation to hypoxia, the significance
of succinate oxidase oxidation gradually declines. In this
process, the electron transport function of the NAD-dependent
oxidation pathway gradually recovers, and the efficiency of C-
I performance increases (Lukyanova et al., 2008a,b, 2009a).
This may be related with the adaptation-induced emergence
of new isoforms of the major complex I enzyme with new
kinetic properties, which enhances the complex efficiency in high
reduction of the pyridine nucleotide pool. Maintaining the high
activity of C-II in these conditions may hamper the process.
Therefore, succinate contributes to formation of both
immediate and delayed mechanisms of adaptation and resistance
to hypoxia.
Brain Mitochondria and HIF-1
Transcriptional Activity in Hypoxia
According to current concepts, the leading role in development
of adaptation to hypoxia belongs to hypoxia-inducible factor
1 (HIF-1), a specific protein factor induced by hypoxia. This
factor discovered in the early 1990s (Wang and Semenza, 1993;
Semenza, 2002, 2007, 2009) functions as the major regulator
of oxygen homeostasis. HIF-1 is a mechanism that the body
uses to respond to hypoxia by controlling expression of proteins
responsible for oxygen delivery to cells, i.e., HIF-1 mediates cell
adaptive responses to changes in tissue oxygenation.
HIF-1 is a heterodimeric redox-sensitive protein consisting
of two subunits, the cytoplasmic inducible, oxygen-sensitive
α subunit (Semenza, 2002, 2007, 2009), which is expressed
in practically all mammalian cells, and the constitutive α
subunit. The HIF-1 activity depends primarily on the HIF-1α
subunit whose synthesis is controlled by the MAPK and P13K
signaling systems activated by the tyrosine kinase receptor.
The receptor agonists include tyrosine hydroxylase, cytokines,
growth factors (such as insulin-like factor), and succinate.
Normally, the intracellular level of HIF-1α subunit is low because
this subunit undergoes proteasomic degradation in oxygen-
dependent reactions of prolyl hydroxylation and ubiquitination.
Hypoxia creates prerequisites for inactivation of prolyl
hydroxylase reactions and thereby provides HIF-1α stabilization
and accumulation, induction of HIF-1α transcription and
translocation to the nucleus, HIF-1α heterodimerization with
the HIF1 β/ARNT subunit, formation of the active transcription
complex HRE, expression of HIF-1 dependent target genes, and
synthesis of protective, adaptive proteins (Semenza, 2002, 2007,
2009; Kim et al., 2006).
Our investigations have shown that under hypoxic
preconditioning, neither free-radical processes nor cytokines
and NO perform the function of signaling mechanisms for
immediate adaptation responsible for the accumulation of
HIF-1α in the early posthypoxic period, and they are likely to
be only secondary messengers playing an important role in
the formation of delayed adaptation (Kirova et al., 2013, 2014;
Lukyanova, 2014).
At the same it is known that oxygen-dependent process
of HIF-1α prolyl-hydroxylation and proteasomic degradation
occurring in the cytosol of normoxic cells is coupled with
utilization of the NAD-dependent substrate of TAC cycle, α-
ketoglutarate, while another TAC cycle substrate, succinate, is an
allosteric inhibitor of this process (Semenza, 2002, 2007, 2009;
Hewitson et al., 2007). Hypoxia inhibits the malate-aspartate
bypass, which provides α-ketoglutarate to the cytosol, whereas
succinate synthesis is intensified. This creates prerequisites
(along with O2 and Fe
2+ shortage) for inactivation of prolyl
hydroxylase reactions and HIF-1α stabilization, accumulation
and potentiation of HIF-1α transcriptional activity.
Now it is proved that functioning of the mitochondrial
respiratory chain is coupled with the hypoxia-induced
transcriptional expression of HIF-1α. It was shown that even
a partial (20%) suppression of C-II activity almost completely
inhibited the hypoxic induction of HIF-1α. However it recovered
in the presence of succinate (Vaux et al., 2001; Paddenberg et al.,
2003; Napolitano et al., 2004; Selak et al., 2005; Hewitson et al.,
2007; Koivunen et al., 2007).
We have also shown, that induction of HIF-1α requires a low
C-1 activity and a high C-II activity, i.e., potentiation of succinate
oxidation (Lukyanova et al., 2008b, 2009b, 2011; Kirova et al.,
2013, 2014; Lukyanova, 2014). If that is the case, a relationship
should exist between activation of the succinate oxidase oxidation
pathway and HIF-1α formation in hypoxia (Figure 2).
However, it should be kept in mind that excessive tissue
accumulation of succinate in pathological conditions related with
impairment of the SDH oxidative function or deficiency of this
enzyme may result in excessively high tissue content of HIF-
1α and, eventually, uncontrolled potentiation of proliferation,
encephalomyopathy, and tumors (Chávez et al., 2000). Thus,
succinate dehydrogenase mutations were shown to induce renal,
gastric, and thyroid carcinoma, and degeneration of striatal spiny
neurons (Huntington‘s disease) (Baysal, 2003; Selak et al., 2005).
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FIGURE 2 | Interaction of succinate oxidase-mediated oxidation (C-II) and HIF-1α transcriptional activity in hypoxia. Activation of C-II contributes to
inhibition of prolyl hydroxylase-mediated reactions (PHD) HIF-1α accumulation and translocation to the nucleus, and expression of HIF-1α-dependent adaptation
genes. C-II, C-III, C-IV - mitochondrial enzyme complexes; TAC, tricarbonic acid cycle; PHD, prolyl hydroxylase-mediated reaction.
Brain Expression of the
Succinate-Dependent Receptor, GPR91, in
Hypoxia
Hypoxic reprogramming and switching of the respiratory chain
to the succinate oxidase oxidation pathway creates prerequisites
for induction of another succinate oxidase signaling pathway,
the expression of GPR91 receptor. In 2004, it was shown that
succinate, a substrate for the TAC and SDH, the respiratory chain
enzyme (C-II), was a specific ligand of GPR91, a metabotropic,
purinergic, G protein-coupled receptor from the P2Y family
localized in the plasma membrane (He et al., 2004). Succinate-
stimulated expression of GPR91 is coupled with activation of
Gq/11, Go and Gi signaling pathways (He et al., 2004; Vargas
et al., 2009). The Gq/11 subfamilies activate phospholipase
Cβ, which converts phosphatidylinositol-4,5,-bisphosphate into
inositol-1,4,5-trisphosphate and diacylglycerol (Fraser, 2008).
Members of the Gi family, including, Go, activate a variety of
phospholipases and phosphodiesterases, and promote opening of
several ion channels. Gi family members can inhibit a subset of
enzymes, thereby controlling the intracellular concentrations of
cAMP (Hamm, 1998). Inhibition of Gi causes strong impairment
of lymphocyte migration in vitro (Kaslow and Burns, 1992),
suggesting that signaling through the Gi is involved in cell
motility processes.
The succinate-dependent receptor, GPR91, is identified in
more than 20 tissues (Stroka et al., 2001). The list of GPR91
localizations have been continuously expanding. The role of
GPR91 is best studied for kidneys where the succinate-dependent
expression of GPR91 involves the renin-angiotensin system
and promotes development of renovascular hypertension, which
is closely associated with atherosclerosis, diabetes, and renal
insufficiency (He et al., 2004; Correa et al., 2007; Sadagopan
et al., 2007; Sapieha et al., 2008; Toma et al., 2008; Vargas et al.,
2009; Kermorvant-Duchemin et al., 2010; Deen and Robben,
2011). This activation is a part of a kidney-specific, paracrine
signaling pathway initiated by high glucose concentrations. The
GPR91 signaling cascade in kidneys includes local accumulation
of succinate and expression and internalization of GPR91 in
endothelial cells of kidney tubules. In the process of signal
transduction, increased endothelial Ca2+ and formed NO and
prostaglandin E2 exert a paracrine effect on adjacent renin-
producing cells. This cascade can modulate renal function and
facilitate elimination of metabolites by hyperfiltration.
The succinate-dependent GPR91 expression was found in
the rodent retinal ganglion cell layer (Sapieha et al., 2008);
in ischemic dendrite cells where GPR91 also functions as a
trigger for Ca2+ mobilization and induction of proinflammatory
cytokines (Rubic et al., 2008); in penumbra neurons and
astrocytes of infracted brain where GPR91 stimulates an increase
in microvessel density (Hamel et al., 2014); in hemopoietic
progenitor cells where GPR91 stimulates their growth (Hakak
et al., 2009). In hepatic ischemia, GPR91 is expressed only
in hepatic stellate cells (Correa et al., 2007). In this case, the
succinate-dependent effect is not related with hypertension.
The receptor transforms the signal of increased extracellular
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succinate concentration into an intracellular signal, which
provides activation of stellate cells in response to liver damage.
Information about the functional role of GPR91 is practically
limited to these reports, which, however, do not answer the
questions, what place the receptor occupies in the body response
to hypoxia, and how GPR91 interacts with other signaling
systems. According to our data, in the normoxic conditions, the
succinate dependent receptor, GPR91, was present in all studied
aerobic tissues. However GPR91 was absent in mitochondria-
free red cells, which indirectly evidenced GPR91 dependence on
mitochondria. The highest density of GPR91 was observed in the
myocardium where the GPR91 density was 1.7 times higher than
in BC and 2.7 times higher than in liver and kidneys (Lukyanova
et al., accepted).
We have also shown that the immediate GPR91 expression
response to a single hypoxic exposure is tissue-specific, depends
on the intensity and duration of the hypoxic exposure, and
its intensity does not correlate with the baseline receptor
concentration. Thus, the baseline GPR91 concentration was the
highest in the myocardium. However, the intensity of GPR91
expression induced by mild and moderate hypoxia was low and
increased slowly. The GPR91 baseline concentration in the BC
was half the myocardial concentration. Nevertheless, the GPR91
induction was observed in the BC in a broader range of low
O2 in the inhaled air than in the myocardium and liver and
was highly intensive (Lukyanova et al., accepted). These facts
indicate higher reactivity and sensitivity to oxygen shortage of
this succinate-dependent signaling system in the BC than in other
studied organs, which may reflect a special significance of this
system to the brain under the hypoxic conditions. FIO2 = 14% is
a threshold value for GPR91 induction in the BC. In other tissues,
GPR91 expression is not induced by these oxygen concentrations
in inhaled air.
As distinct from a single, hypoxic session, repeated 60-min
exposures (moderate hypoxia) induced a phase of delayed GPR91
expression in the BC, which formed regardless of whether
the immediate phase of receptor expression was induced. The
delayed phase developed following 5–8 sessions and reached
a peak at 8–12 days. The delayed phase contemporized with
development of delayed, non-specific tolerance of the body
(Lukyanova et al., 2009a; Lukyanova et al., accepted). In none
of the studied tissues, the phase of delayed GPR91 expression
developed after a single hypoxic exposure.
Therefore, the succinate-dependent receptor, GPR91, is
involved in the mechanism of formation of both immediate and
delayed adaptation to hypoxia. The immediate GPR91 induction
was the most intensive in hypoxic BC, which implied a high
significance of this signaling pathway for the brain functioning.
The fact that the phase of delayed GPR91 expression did not
develop after a single hypoxic exposure and required repeated
hypoxic sessions suggested that the mechanism of delayed phase
formation did not depend on the immediate GPR91 expression
but was mediated by other processes developing during a later
phase.
The typical for BC immediate hypoxic expression of GPR91
may reflect a local increase in tissue succinate consistent with
the hypoxic exposure and followed by succinate binding to the
receptor as a paracrine signal. In the brain, the GABA bypass
(Roberts cycle) may be a source of succinate in hypoxia. This
brain-specific cycle consists of successive biochemical reactions
activated by hypoxia/ischemia. In these reactions, gamma-
aminobutyric acid (GABA) transforms to succinic acid, a C-
II (SDH) substrate, through an intermediate step of succinic
semialdehyde (Figure 3).
We have tested a possibility of using succinate formed in this
cycle in the BC as a specific ligand for the GPR91 receptor. When
the activity of glutamate decarboxylase, an enzyme responsible
for GABA synthesis, modulation of the GABA bypass activity,
and local endogenous formation of succinate, was inhibited with
thiosemicarbazide (TSC), the immediate GPR91 expression was
not observed in the BC under moderate hypoxia (Lukyanova
et al., accepted). However, when TSC was administered together
with succinate-containing agents (mexidol, proxipin, sodium
succinate), the tissue receptor density recovered and was only
slightly lower than the receptor density without the GABA
inhibitor. These data demonstrate dependence of the GPR91
expression in the BC on succinate formed in hypoxia-induced
reactions of the GABA bypass. This dependence, in its turn,
suggests that in the BC, the induction of the succinate-dependent
receptor, GPR91, performs a specific function in hypoxia. This
function is related with the bypass performance and focused
on elimination of glutamate excitotoxicity and maintenance of
aerobic oxidation due to activation of the succinate-dependent
pathway catalyzed by C-II. Therefore, the BC-specific immediate
hypoxic expression of the succinate-dependent receptor, GPR91,
is related with activity of the GABA bypass, which functions as
a source of succinate both for the receptor and the respiratory
chain.
Pharmacological Methods for Protection of
the Brain Respiratory Chain in Hypoxia
Prevalence of pathologies related with the disturbed function
of C-I in both normoxic and hypoxic conditions, defines the
exceptional importance and social significance of protecting the
respiratory chain from oxygen shortage and protecting the body
from the accompanying energy deficiency.
At present, two approaches to solving this problem exist—
pharmacological and physical-therapeutic. The first approach
(energotropic therapy) is based on the use of drugs containing
an active substance that can interact with the mitochondrial
respiratory chain and activate C-I bypassing oxidation pathways
while the respiratory chain cytochrome region remains intact.
This provides fast reversal of the energy deficiency induced by
dysfunction of the NADH-dependent region.
The second approach (hypoxic therapy) is based on repeated
exposures to mild hypoxia regimens (hypoxic preconditioning).
These exposures induce a variety of adaptive responses,
including formation of new isoforms of C-I enzymes with new
redox properties, which allow C-I to function in the hypoxic
conditions. Non-specific stress resistance of the body increases
simultaneously.
The leading place among energotropic medicines belongs to
succinate-containing drugs which have been successfully used
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FIGURE 3 | Interaction of the respiratory chain and the GABA bypass aimed at formation of succinate, a GPR91 ligand, in hypoxic BC.
as effective antihypoxic and adaptogenic compounds. The most
effective of these drugs are structural derivatives of vitamin B6,
which belong to 3-oxypyridine derivatives (mexidol, proxipin).
These drugs are used in the early phase of acute disorders related
with oxygen shortage (Luk’yanova et al., 1990; Kondrashova,
1993; Lukyanova and Dudchenko, 1999; Lukyanova et al.,
2009a,b,c; Lukyanova, 2005; Nowak et al., 2008).
All succinate-containing drugs are very rapidly absorbed in
the setting of different types of hypoxia/ischemia. They exert
stabilizing or restoring effect on intracellular ATP as soon as
in 15min after administration. Studies of their mechanism
showed that the respiratory chain uses succinate incorporated
in the drug structure as an energy substrate. This process
stimulates respiration and switches the electron flow from C-I
to C-II (succinate monopolization of the respiratory chain
proven by the increased respiration sensitivity to malonate and
the reduced rotenone-sensitive respiration due to oxidation
of NAD-dependent substrates) (Lukyanova and Dudchenko,
1999). Thus, succinate-containing drugs are succinate donors
for the respiratory chain. In the hypoxic conditions, they
function as antihypoxants potentiating activation of the
succinate oxidase oxidation pathway to facilitate recovery and
normalization of aerobic energy production (Lukyanova et al.,
2009a).
Energotropic and antihypoxic effects of succinate-containing
compounds are associated with (1) pronounced antioxidant
properties; (2) modification and resynthesis of phospholipids,
which decrease the membrane ionic permeability and K+
outflow from mitochondria by the concentration gradient; (3)
normalizing effect on calcium metabolism; (4) catecholamine-
mimetic, antiteratogenic, antitoxic, hepatoprotective,
antiketogenic, and anticholesterolemic effects; (5) removal
of excessive acetyl-Co-A associated with decreases in excessive
lipids and their metabolites; (6) reduction and normalization of
pH and elimination of metabolic acidosis (Kondrashova, 1993;
Maevsky et al., 2001).
Along with the energotropic and antihypoxic effects,
succinate-containing compounds beneficially influenced
multiple vital functional parameters in the conditions of
hypoxia and ischemia. These drugs reduced the death rate,
recovered the body capability for gaining weight, decreased
severity of neurological disorders and aggression typical for
hypoxia, exerted antistress and normalizing effects on locomotor,
exploratory, and emotional activities of animals (Luk’yanova
et al., 1990; Lukyanova, 2005; Lukyanova et al., 2009a,b).
Proxipin and mexidol are characterized by a broad range of
pharmacological actions. In addition to pronounced antioxidant
and psychotropic properties, they are able to increase resistance
of the body to different types of hypoxia, reduce ATP losses in
ischemic brain and myocardium, and normalize the process of
oxidative phosphorylation (Lukyanova, 1997, 2005; Lukyanova
and Dudchenko, 1999; Lukyanova et al., 2009b).
It should be also kept in mind that beneficial effects
of succinate-containing drugs are supplemented with their
modulating effects on the HIF-1α transcriptional activity and
the coupled expression of genes for immediate and delayed
adaptation, and involvement of critical intracellular signaling
pathways via the succinate-dependent receptor, GPR91.
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FIGURE 4 | Mitochondrial signaling in cell-to-cell interactions at hypoxia. Reprogramming of the mitochondrial respiratory chain function in hypoxia is a
regulatory and compensatory mechanism, which provides: (1) activation of succinate oxidation, a more efficient pathway of energy production in the conditions of
rapidly progressing oxygen shortage (A); (2) succinate-dependent PDH inhibition, subsequent stabilization of HIF-1α, and initiation of HIF-1α transcriptional activity (B);
(3) succinate-dependent activation of the GPR91 signaling pathway and related signaling pathways, stimulation of HIF-1α synthesis and transcriptional activity (C).
All this provides that the succinate therapy used in the early
phase of acute disorders, i.e., during formation of immediate
adaptive mechanisms (first 1–3 days of global cerebral ischemia,
stroke, myocardial infarction, acute heart failure, traumatic
shock, recovery after heart arrest, early postoperative period, after
anesthesia, etc.,) exerts a pronounced protective, antihypoxic
effect, and increases ATP in tissues.
Conclusion
The data provided above show that the mitochondrial respiratory
chain not only directily contribiutes to the development of both
early and late adaptive responses in the conditions of hypoxia
but is also involved in a sophisticated system of intra- and
intercellular signaling, which provides formation of a systemic
response to oxygen shortage.
The response to hypoxia initially mediated by C-I inhibition
and C-II activation at the subcellular (mitochondrial) level
triggers a cascade of succinate-dependent, interacting regulatory
reactions, which develop at both cellular and systemic levels and
regulate the maintenance of oxygen homeostasis in the body
(Figure 4).
Transient, reversible, compensatory activation of respiratory
chain complex II is a major mechanism of immediate adaptation
to hypoxia necessary for (1) succinate-related energy synthesis
in the conditions of oxygen deficiency and formation of urgent
resistance in the body; (2) succinate-related stabilization of
HIF-1α and initiation of its transcriptional activity related
with formation of long-term adaptation; (3) succinate-related
activation of the succinate-specific receptor, GPR91.
This mechanism participates in at least four critical regulatory
functions: (1) sensor function related with changes in kinetic
properties of C-I and C-II in response to a gradual decrease
in ambient oxygen concentration; this function is designed for
selection of the most efficient pathway for energy substrate
oxidation in hypoxia; (2) compensatory function focused on
formation of immediate adaptive responses to hypoxia and
hypoxic resistance of the body; (3) transcriptional function
focused on activated synthesis of HIF-1 and the genes providing
long-term adaptation to low pO2; (4) receptor function,
which reflects participation of mitochondria in the intercellular
signaling system via the succinate-dependent receptor, GPR91.
In all cases, the desired result is achieved by activation
of the succinate-dependent oxidation pathway, which allows
considering succinate as a signaling molecule.
Therefore the overall response of the body to oxygen shortage
reflects a sophisticated, evolutionarily formed, multifunctional
cell response, where energy metabolism performs a trigger,
coordinating function of a protective signaling mechanism in the
general hierarchy of intracellular processes.
Although succinate-dependent processes occur in different
hypoxic tissues, in the BC these processes are observed in a
greater range of low oxygen concentrations, more coordinated
in time, and more intensive. This suggests, first, well-regulated
endogenous, metabolic, anti-hypoxic defense, and adaptive
capability of the brain and, second, a particular significance of
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brain adaptive processes for the development of tolerance in the
whole body.
Analysis of bioenergetics mechanisms and related succinate-
dependent signaling reactions in different hypoxia regimens
showed that parameters of energy metabolism can be used
as predictors and prognostic criteria for severity of hypoxic
disorders.
The leading regulatory role of mitochondrial respiratory
chain and succinate, its energy substrate, in the development
of immediate adaptation to hypoxia suggests a possibility of
modulating this process to optimize it. Practical medicine
successfully uses various succinate-containing drugs, which exert
beneficial effects in pathologies with a hypoxic component, due
to their antihypoxic and energotropic effects.
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